Drug intelligence / Profile preview

Vascuxin

Development stage: Unknown
Lead developer: GT-Sunway
Administration: Oral

Overview

**Vascuxin** is an oral traditional botanical health product developed by GTSW Bio and registered in Malaysia as MAL07031236T. It is supplied as vegetable capsules containing red yeast rice and green tea extract and is positioned for general and cardiovascular health support. The product is a monacolin K-free red yeast rice supplement; no product-specific molecular target or defined pharmacological mechanism has been disclosed. ([gt-sunway.com](https://www.gt-sunway.com/gt-sw-product))

Brand names: GT-SW Vascuxin CapsulesVascuxin

Beyond the preview

Go deeper on Vascuxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascuxin.

Explore the full profile